Federal Register Notice: FDA’s proposed collection of information, “Investigational New Drug (IND) Regulations — 21 CFR Part 312,” has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
